Trials / Terminated
TerminatedNCT00496067
Uterine Artery Occlusion for Fibroid Related Bleeding
An Evaluation of a Doppler-Guided Uterine Artery Occlusion Device as Treatment for the Reduction of Fibroid-Associated Bleeding
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 91 (actual)
- Sponsor
- Ethicon, Inc. · Industry
- Sex
- Female
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety and effectiveness of Doppler guided Uterine Artery Occlusion (D-UAO) as treatment for the reduction of fibroid-associated symptoms.
Detailed description
DUAO is intended for bilateral occlusion of the uterine arteries
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Doppler-Guided Uterine Artery Occlusion Device | For bilateral occlusion of the uterine arteries |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2007-07-04
- Last updated
- 2011-03-09
Locations
14 sites across 7 countries: Denmark, France, Germany, Netherlands, Norway, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT00496067. Inclusion in this directory is not an endorsement.